Abstract
Peroxisome proliferators-activated receptor γ (PPARγ) is a nuclear hormone receptor that serves as a master regulator for adipocytes-specific genes contributing to adipocytes differentiation, insulin sensitivity and lipid metabolism. The substitution of proline to alanine at codon 12 of the PPAR γ2 gene (Pro12Ala polymorphism) is most widely studied, and the associations with diabetes, obesity, and other clinical parameters have been reported and discussed in several ethnic groups. Among native Qatar ethnicity, however, there is no report about this polymorphism. The aim of this study was to estimate the allele frequency of the Pro12Ala polymorphism of PPAR γ2 gene among Qatari population and investigate the association between this polymorphism and obesity or type 2 diabetes. This is a matched case–control study. It was carried out among diabetic patients and healthy subjects at the Primary Healthcare Clinics, and the survey was conducted from February 2003 to March 2006 in Qatari male and female nationals aged 35 to 60 years. The study was based on matched age, sex, and ethnicity of 400 cases (with diabetes) and 450 controls (without diabetes). Face-to-face interviews were based on a questionnaire that included variables such as age, sex, sociodemographic status, body mass index (BMI), and obesity. Their health status was assessed by medical conditions, family history, and blood pressure measurements. The allele frequency of Pro12Ala polymorphism in PPAR γ2 gene among Qataris is lower than that in many Caucasian ethnic groups. No association is seen between the Pro12Ala and type 2 Diabetes (0.055 vs 0.059, OR = 1.1311, P = 0.669). Nearly half of the diabetic type 2 patients (48.5%) were obese (BMI > 30) compared to nondiabetic subjects (29.8%) (P < 0.001). In this study, no association is seen between the Pro12Ala polymorphism in PPAR γ2 gene and the type2 diabetes in Qatar.
Similar content being viewed by others
References
Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R (2003) Molecular mechanism of insulin resistance and obesity. Exp Biol Med 228:1111–1117
Stumvoll M, Haring H (2002) Perspective in diabetes: The peroxisome proliferators-activated receptor γ2 Pro12Ala polymorphism. Diabetes 50:2341–2347
Barroso I, Gurnell M, Crowley VEF et al (1999) Dominant negative mutations in human PPAR γ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402(6764):880–883
Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K (2005) A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia. Diabetes Metab Res Rev 21:465–469
Tavares V, Hirata RD, Rodrigues AC, Monte O, Salles JE, Scalissi N, Speranza AC, Hirata MH (2005) Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus. Diabetes Obes Metab 7:605–611
Giusti V, Verdumo C, Sutter M, Gaillard RC, Burckhardt P, Pralong F (2003) Expression of PPAR γ 2 in visceral and subcutaneous adipose tissue of obese women. Diabetes 52:1673–1676
Fajas L, Auboeuf D, Raspe E et al (1997) The organization, promoter analysis, and expression of the human PPAR γ gene. J Biol Chem 272:18779–18789
Bener A, Zirie M, Al-Rikabi R (2005) Genetics, obesity and environmental risk factors associated with type 2 diabetes. Croat Med J 46:302–307
Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, Tauber M, Weill J, Froguel P (2005) Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 6:11
Deeb SS, fajas L, Nemoto M et al (2004) A Pro12Ala substitution in PPAR γ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287
Frederiksen L, Broadbaek K, Fenger M et al (2002) Comment: studies of the Pro12Ala polymorphism of the PPAR gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 87:3989–3992
Mori H, Ikegami H, Kawaguchi Y et al (2001) Brief genetics report the Pro12 → Ala substitution in PPAR γ is associated with resistance to development of diabetes in the general population possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50:891–894
Altshuler D, Hirschhorn JN, Klannenmark M et al (2000) The common PPAR Pro12ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80
Masud S, Ye S, SAS group (2003) Effect of the peroxisome proliferators activated receptor γ2 Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 40:773–780
Beamer BA, Yen C-J, Andersen RE et al (1998) Brief genetics report: association of the Pro12Ala variant in the PPAR γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806–1809
Tai ES, Corella D, Yap MD et al (2004) Differential effects of the C1431T and Pro12Ala PPAR γ2 variants on plasma lipids and diabetes risk in an Asian population. J Lipids Res 45:674–685
Oh EY, Min KM, Chung JH et al (2000) Significance of Pro12Ala mutation in peroxisome proliferators-activated receptor γ2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 85:1801–1804
Muller YL, Bogardus C, Beamer BA, Shuldiner AR, Baier LJ (2003) A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes 52:1864–1871
Rosmond R, Chagnon M, Bouchard C (2003) The Pro12Ala PPAR γ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab Res Rev 19:159–163
Sanchez JLG, Rios MS, Perez CF, Laakso M, larrad MTM (2002) Effect of the Pro12Ala polymorphism of the peroxisome proliferators activated receptor γ 2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. J Eur Endocrinol 147:495–501
American Diabetes Association (2004) Diagnosis classification of diabetes mellitus. Diabetes Care 27:S5–S10
World Health Organization (1999) International society of hypertension guidelines for the management of hypertension. J Hypertens 17:151–182
Stumvoll M, Haring H (2002) Perspectives in diabetes: the peroxisome proliferator–activated receptor-γ 2 Pro12Ala polymorphism. Diabetes 51:2341–2347
de Pablos-Velasco PL, Martinez-Martin FJ, Rodriguez-Perez A et al (2001) Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population comparison of the 1997 ADA and the 1985 WHO criteria. The Guia study. Diabet Med 18:235–341
Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MIJ (2001) Effect of the Pro12Ala polymorphism of the PPAR γ2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 44:925–926
Hasstedt SJ, Ren Q-F, teng K, Elbein SC (2001) Effect of the peroxisome proliferators-activated receptor-γ2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial Type2 diabetic kindreds. J Clin Endocrinol Metab 86:536–541
Luan J, Browne PO, Harding AH et al (2001) Evidence for gene-nutrient interaction at the PPAR γ locus. Diabetes 50:686–689
Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A et al (2003) Peroxisome proliferators-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension. J Hypertens 21:1649–1655
Zouari Bouassida K, Chouchane L, Jellouli K, Cherif S, Haddad S, Gabbouj S, Danguir J (2005) The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients. Diabetes Metab 31:119–23
Sutanegara D, Darmono, Budhiarta AAG (2000) The epidemiology and management of diabetes mellitus in Indonesia. Diabetes Res Clin Pract 50(Suppl 2):S9–S16
Bener A, Alali KA (2006) Consanguineous marriage in a newly developed country: the Qatari population. J Biosoc Sci 38:239–246
Bener A, Hussain R (2006) Consanguineous unions and child health in Qatar. Paediatr Perinat Epidemiol 20:372–378
Acknowledgments
The project was supported and funded by Hamad Medical Corporation (HMC) Grant No. 231. We would like to thank Hamad Medical Corporation and Diabetic Association for generous support and help while this project was conducted. We also thank the technical staff of the Molecular Genetics Laboratory of the HMC for their technical contribution to this study, in particular, Aisha Al-Khelaifi, Ali Alavi, Mashael Al-Jaber, and Irene D’Souza.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Badii, R., Bener, A., Zirie, M. et al. Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Acta Diabetol 45, 15–21 (2008). https://doi.org/10.1007/s00592-007-0013-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-007-0013-8